Patient-derived organotypic tissue cultures as a platform to evaluate metabolic reprogramming in breast cancer patients
Open Access
- 9 April 2025
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (5) , 108495
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R21EB032515, 5P20GM121327, P30CA177558)
This publication has 55 references indexed in Scilit:
- Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor‐positive breast cancer via regulation of the mTOR pathwayCancer Medicine, 2022
- O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycleJournal of Bioenergetics and Biomembranes, 2018
- Chloroformate derivatization for tracing the fate of Amino acids in cells and tissues by multiple stable isotope resolved metabolomics (mSIRM)Analytica Chimica Acta, 2017
- Mass spectrometry analysis shows the biosynthetic pathways supported by pyruvate carboxylase in highly invasive breast cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast CancerCancer Cell, 2013
- N-glycans in cell survival and death: Cross-talk between glycosyltransferasesBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survivalIUBMB Life, 2012
- Stable isotope resolved metabolomics analysis of ribonucleotide and RNA metabolism in human lung cancer cellsMetabolomics, 2011
- Riboneogenesis in YeastCell, 2011
- Isotopomer analysis of lipid biosynthesis by high resolution mass spectrometry and NMRAnalytica Chimica Acta, 2009